Pipeline
ITB-MED’s portfolio has projects in several focus areas and in various phases from discovery through clinical development. Our project portfolio as of May 28, 2024.
Transplantation
Kidney
Tolerance
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F03%2F125-panorama-color-black-e1711374340376.png&w=3840&q=75)
Tolerance
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F03%2F125-perspective-color-black.png&w=3840&q=75)
Tolerance
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Delayed Tolerance
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Dual co-stimulation blockade
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F03%2Fascend-color-1-e1711374495740.png&w=3840&q=75)
Induction
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Xenotransplantation
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Liver
Tolerance (non-autoimmune)
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F05%2Fscreenshot-2024-05-28-at-121636.png&w=3840&q=75)
Induction (autoimmune)
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Bone Marrow
GVHD prevention
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
Autoimmunity
Type-1 Diabetes
New-onset remission
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F03%2Fstride-color-1-e1711374554762.png&w=3840&q=75)
New-onset remission
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F05%2Fscreenshot-2024-05-28-at-121817.png&w=3840&q=75)
Amyotrophic Lateral Sclerosis
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
![](/_next/image?url=https%3A%2F%2Fcdn.wntr.io%2Fitb-med.com%2Fproduction%2Fuploads%2F2024%2F05%2Fscreenshot-2024-05-28-at-121827.png&w=3840&q=75)
Hidradenitis Suppurativa
Phase of trial | |||
---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal |
AA Focus | Indication | Phase of trial | |||||
---|---|---|---|---|---|---|---|
IND-Enabling | Phase 1 | Phase 2 | Pivotal | Trial/Partner | |||
Transplantation | Kidney Kidney Kidney Kidney Kidney Kidney Kidney Kidney Liver Liver Liver Bone Marrow Bone Marrow | Tolerance Tolerance Tolerance Delayed Tolerance Dual co-stimulation blockade Induction Xenotransplantation Tolerance (non-autoimmune) Induction (autoimmune) GVHD prevention | company logos ![]() company logos ![]() company logos company logos company logos ![]() company logos company logos company logos ![]() company logos company logos | ||||
Autoimmunity | Type-1 Diabetes Type-1 Diabetes Type-1 Diabetes Amyotrophic Lateral Sclerosis Amyotrophic Lateral Sclerosis Hidradenitis Suppurativa Hidradenitis Suppurativa | New-onset remission New-onset remission | company logos ![]() company logos ![]() company logos ![]() company logos |